Christoph Wetz

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Neuroendocrine Tumors

Multiple Myeloma

Top Venues

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Helena F Pernice, Adrian L Knorz, Paul J Wetzel, Carolin Herrmann, Harisa Muratovic, Finn Rieber, Eleonora Asaad, Gunnar Fiß, Gina Barzen, Elisabeth Blüthner, Fabian Knebel, Sebastian Spethmann, Daniel Messroghli, Bettina Heidecker, Anna Brand, Christoph Wetz, Carsten Tschöpe, Katrin Hahn
Neurological affection and serum neurofilament light chain in wild type transthyretin amyloidosis. Scientific reports 14 (1) (2024)
Helena F Pernice, Adrian L Knorz, Paul J Wetzel, Carolin Herrmann, Harisa Muratovic, Finn Rieber, Eleonora Asaad, Gunnar Fiß, Gina Barzen, Elisabeth Blüthner, Fabian Knebel, Sebastian Spethmann, Daniel Messroghli, Bettina Heidecker, Anna Brand, Christoph Wetz, Carsten Tschöpe, Katrin Hahn
Neurological affection and serum neurofilament light chain in wild type transthyretin amyloidosis. Scientific reports 14 (1) (2024)
Helena F Pernice, Adrian L Knorz, Paul J Wetzel, Carolin Herrmann, Harisa Muratovic, Finn Rieber, Eleonora Asaad, Gunnar Fiß, Gina Barzen, Elisabeth Blüthner, Fabian Knebel, Sebastian Spethmann, Daniel Messroghli, Bettina Heidecker, Anna Brand, Christoph Wetz, Carsten Tschöpe, Katrin Hahn
Neurological affection and serum neurofilament light chain in wild type transthyretin amyloidosis. Scientific reports 14 (1) (2024)
Helena F Pernice, Adrian L Knorz, Paul J Wetzel, Carolin Herrmann, Harisa Muratovic, Finn Rieber, Eleonora Asaad, Gunnar Fiß, Gina Barzen, Elisabeth Blüthner, Fabian Knebel, Sebastian Spethmann, Daniel Messroghli, Bettina Heidecker, Anna Brand, Christoph Wetz, Carsten Tschöpe, Katrin Hahn
Neurological affection and serum neurofilament light chain in wild type transthyretin amyloidosis. Scientific reports 14 (1) (2024)
Helena F Pernice, Adrian L Knorz, Paul J Wetzel, Carolin Herrmann, Harisa Muratovic, Finn Rieber, Eleonora Asaad, Gunnar Fiß, Gina Barzen, Elisabeth Blüthner, Fabian Knebel, Sebastian Spethmann, Daniel Messroghli, Bettina Heidecker, Anna Brand, Christoph Wetz, Carsten Tschöpe, Katrin Hahn
Neurological affection and serum neurofilament light chain in wild type transthyretin amyloidosis. Scientific reports 14 (1) (2024)
Christoph Wetz, Tristan Ruhwedel, Imke Schatka, Jane Grabowski, Henning Jann, Giulia Metzger, Markus Galler, Holger Amthauer, Julian Manuel Michael Rogasch
Plasma Markers for Therapy Response Monitoring in Patients with Neuroendocrine Tumors Undergoing Peptide Receptor Radionuclide Therapy. Cancers 15 (24) (2023)
Christoph Wetz, Tristan Ruhwedel, Imke Schatka, Jane Grabowski, Henning Jann, Giulia Metzger, Markus Galler, Holger Amthauer, Julian Manuel Michael Rogasch
Plasma Markers for Therapy Response Monitoring in Patients with Neuroendocrine Tumors Undergoing Peptide Receptor Radionuclide Therapy. Cancers 15 (24) (2023)
Markus Galler, Julian Manuel Michael Rogasch, Kai Huang, Henning Jann, Kristina Plehm, Christoph Wetz, Holger Amthauer
Prognostic Value of the Largest Lesion Size for Progression-Free Survival in Patients with NET Undergoing Salvage PRRT with [ 177 Lu]Lu-DOTATOC. Cancers 14 (7) (2022)
Tristan Ruhwedel, Julian Manuel Michael Rogasch, Kai Huang, Henning Jann, Imke Schatka, Christian Furth, Holger Amthauer, Christoph Wetz
The Prognostic Value of the De Ritis Ratio for Progression-Free Survival in Patients with NET Undergoing [177Lu]Lu-DOTATOC-PRRT: A Retrospective Analysis. Cancers 13 (4) (2021)
Emin Gültekin, Christoph Wetz, Jürgen Braun, Dominik Geisel, Christian Furth, Bernd Hamm, Ingolf Sack, Stephan Rodrigo Marticorena Garcia
Added Value of Tomoelastography for Characterization of Pancreatic Neuroendocrine Tumor Aggressiveness Based on Stiffness. Cancers 13 (20) (2021)
Christoph Wetz, Philipp Genseke, Ivayla Apostolova, Christian Furth, Sammy Ghazzawi, Julian M M Rogasch, Imke Schatka, Michael C Kreissl, Frank Hofheinz, Oliver S Grosser, Holger Amthauer
The association of intra-therapeutic heterogeneity of somatostatin receptor expression with morphological treatment response in patients undergoing PRRT with [177Lu]-DOTATATE. PloS one 14 (5) (2019)